FR2440192A1 - Suppositoires stabilises contenant des alcaloides de l'ergot - Google Patents
Suppositoires stabilises contenant des alcaloides de l'ergotInfo
- Publication number
- FR2440192A1 FR2440192A1 FR7831201A FR7831201A FR2440192A1 FR 2440192 A1 FR2440192 A1 FR 2440192A1 FR 7831201 A FR7831201 A FR 7831201A FR 7831201 A FR7831201 A FR 7831201A FR 2440192 A1 FR2440192 A1 FR 2440192A1
- Authority
- FR
- France
- Prior art keywords
- suppository
- stabilised
- suppositories
- migraine
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
L'INVENTION CONCERNE DES SUPPOSITOIRES STABILISES CONTENANT DES ALCALOIDES DE L'ERGOT ETOU LEURS DERIVES. SELON L'INVENTION, ON AJOUTE PAR SUPPOSITOIRE 0,2 A 5MG DE SUBSTANCES FINEMENT DIVISEES LIBERANT DU DIOXYDE DE SOUFRE. L'ERGOTAMINE EST STABILISEE DANS LES SUPPOSITOIRES SELON L'INVENTION PENDANT 33MOIS A LA TEMPERATURE AMBIANTE.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7831201A FR2440192A1 (fr) | 1978-11-03 | 1978-11-03 | Suppositoires stabilises contenant des alcaloides de l'ergot |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7831201A FR2440192A1 (fr) | 1978-11-03 | 1978-11-03 | Suppositoires stabilises contenant des alcaloides de l'ergot |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2440192A1 true FR2440192A1 (fr) | 1980-05-30 |
FR2440192B1 FR2440192B1 (fr) | 1983-01-21 |
Family
ID=9214457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7831201A Granted FR2440192A1 (fr) | 1978-11-03 | 1978-11-03 | Suppositoires stabilises contenant des alcaloides de l'ergot |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2440192A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655854A1 (fr) * | 1989-12-19 | 1991-06-21 | Poissonnet Claude | Medication nouvelle pour le traitement de surcharges lipidiques. |
-
1978
- 1978-11-03 FR FR7831201A patent/FR2440192A1/fr active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655854A1 (fr) * | 1989-12-19 | 1991-06-21 | Poissonnet Claude | Medication nouvelle pour le traitement de surcharges lipidiques. |
Also Published As
Publication number | Publication date |
---|---|
FR2440192B1 (fr) | 1983-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL86170A0 (en) | Preparations containing nicotine | |
GR3004941T3 (fr) | ||
PT75384A (en) | Process for the preparation of cyclic peptidic ergot alkaloids and of pharmaceutical composition containing them | |
ES8100296A1 (es) | Un procedimiento para la extraccion de cafeina de una solucion que la contiene | |
FR2440192A1 (fr) | Suppositoires stabilises contenant des alcaloides de l'ergot | |
HU178084B (en) | New process for the extraction of native vindoline,catharantine,3',4'-anhydrovinblastine,leurosine and,if desired,of other diinodle alkaloids from vinca rosea l.drogue | |
JPS54107914A (en) | Production of high density silicon nitride base sintered body | |
JPS56140022A (en) | Low density body of prepared mixture for use in manufacture of silicon and ferrosilicon | |
IL51593A0 (en) | Process and compositions for treatment of leukemia and other tumors comprising 10-deazaminopterin | |
IL58421A (en) | Production of(2'-5')oligoisoadenylate and pharmaceutical compositions containing it | |
EP0302421A3 (en) | Alpha-carotene for inhibiting the growth of cancer cells | |
GB2125292B (en) | Stable aqueous formulations of vinca alkaloids | |
DE2963545D1 (en) | Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation | |
JPS52105220A (en) | Composition for rectal administration comprising beta-lactam ring containing substance and method of making same | |
NO179838C (no) | Fremgangsmåte for fremstilling av S-(-)-3-morfolino-4-(3-tert-butylamino-2-hydroksypropoksy)-1,2,5-tiadiazol-hemihydrat | |
IL49668A0 (en) | Stable solutions of ergot alkaloids,their preparation and pharmaceutical compositions comprising them | |
PH20385A (en) | Ergot alkaloids, compositions containing the same and method of use thereof | |
ES8100076A1 (es) | Un procedimiento para preparar supositorios | |
GB2014031B (en) | Reducing the nitrogen content of tobacco | |
DE2961653D1 (en) | Alkylaminopropanol derivatives of 3-alkyl-5-(2-hydroxystyryl)-isoxazoles, processes for their preparation and therapeutical compositions containing them | |
ZA806554B (en) | Amino derivatives of 2-methyl-5-(2-hydroxystyryl)-1,3,4 thiadiazole,their preparation,and formulations containing these compounds | |
DE3477882D1 (en) | Gonadoliberin and gonadoliberin agonists in the treatment of metabolic diseases due to too small a parathormone level | |
Young et al. | Intrapatient variability of serial plasma chlorpromazine concentrations. | |
USD225273S (en) | Sample cutter | |
USD226336S (en) | Ball jointed pen holder and the like |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |